{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:25:29Z","timestamp":1791321929698,"version":"4.3.1"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circulation"],"published-print":{"date-parts":[[1996,8]]},"abstract":"<jats:p>\n            <jats:italic>Background<\/jats:italic>\n            Angiotensin-converting enzyme (ACE) inhibitors may exert some of their benefits in the therapy of hypertension, congestive heart failure, and acute myocardial infarction by their improvement of endothelial dysfunction. TREND (Trial on Reversing ENdothelial Dysfunction) investigated whether quinapril might improve endothelial dysfunction in normotensive patients with coronary artery disease and no heart failure, cardiomyopathy, or major lipid abnormalities so that confounding variables that affect endothelial dysfunction could be minimized.\n          <\/jats:p>\n          <jats:p>\n            <jats:italic>Methods and Results<\/jats:italic>\n            Using a double-blind, randomized, placebo-controlled design, we measured the effects of quinapril (40 mg daily) on coronary artery diameter responses to acetylcholine using quantitative coronary angiography. The primary response variable was the net change in the acetylcholine-provoked constriction of target segments between the baseline (prerandomization) and 6-month follow-up angiograms. The constrictive responses to acetylcholine were comparable in the placebo (n=54) and quinapril (n=51) groups at baseline. After 6 months, only the quinapril group showed significant net improvement in response to incremental concentrations of acetylcholine (4.5\u00b13.0% [mean\u00b1SEM] versus \u22120.1\u00b12.8% at 10\n            <jats:sup>\u2212<\/jats:sup>\n            <jats:sup>6<\/jats:sup>\n            mol\/L and 12.1\u00b13.0% versus \u22120.8\u00b12.9% at 10\n            <jats:sup>\u2212<\/jats:sup>\n            <jats:sup>4<\/jats:sup>\n            mol\/L, quinapril versus placebo, respectively; overall\n            <jats:italic>P<\/jats:italic>\n            =.002).\n          <\/jats:p>\n          <jats:p>\n            <jats:italic>Conclusions<\/jats:italic>\n            TREND shows that ACE inhibition with quinapril improved endothelial dysfunction in patients who were normotensive and who did not have severe hyperlipidemia or evidence of heart failure. These benefits of ACE inhibition are likely due to attenuation of the contractile effects and superoxide-generating effects of angiotensin II and to enhancement of endothelial cell release of nitric oxide secondary to diminished breakdown of bradykinin.\n          <\/jats:p>","DOI":"10.1161\/01.cir.94.3.258","type":"journal-article","created":{"date-parts":[[2012,6,12]],"date-time":"2012-06-12T00:34:42Z","timestamp":1339461282000},"page":"258-265","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":749,"title":["Angiotensin-Converting Enzyme Inhibition With Quinapril Improves Endothelial Vasomotor Dysfunction in Patients With Coronary Artery Disease"],"prefix":"10.1161","volume":"94","author":[{"given":"G.B. John","family":"Mancini","sequence":"first","affiliation":[{"name":"the University of British Columbia, Vancouver, British Columbia, Canada (G.B.J.M.); Parke-Davis Pharmaceutical Research, Ann Arbor, Mich (G.C.H., M.I.K., H.E.H., A.C.G.U.); Hospital Clinico Universitaro, Madrid, Spain (C.M.); Dalhousie University, Halifax, Nova Scotia, Canada (B.J.O.); Westchester County Medical Center, Valhalla, NY (A.L.P.); St Paul's Hospital, Vancouver, British Columbia, Canada (R.G.C.); University of Florida, Gainesville (T.J.W., C.J.P.); Klinikum Innenstadt der Universita\u00a8t,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory C.","family":"Henry","sequence":"additional","affiliation":[{"name":"the University of British Columbia, Vancouver, British Columbia, Canada (G.B.J.M.); Parke-Davis Pharmaceutical Research, Ann Arbor, Mich (G.C.H., M.I.K., H.E.H., A.C.G.U.); Hospital Clinico Universitaro, Madrid, Spain (C.M.); Dalhousie University, Halifax, Nova Scotia, Canada (B.J.O.); Westchester County Medical Center, Valhalla, NY (A.L.P.); St Paul's Hospital, Vancouver, British Columbia, Canada (R.G.C.); University of Florida, Gainesville (T.J.W., C.J.P.); Klinikum Innenstadt der Universita\u00a8t,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Macaya","sequence":"additional","affiliation":[{"name":"the University of British Columbia, Vancouver, British Columbia, Canada (G.B.J.M.); Parke-Davis Pharmaceutical Research, Ann Arbor, Mich (G.C.H., M.I.K., H.E.H., A.C.G.U.); Hospital Clinico Universitaro, Madrid, Spain (C.M.); Dalhousie University, Halifax, Nova Scotia, Canada (B.J.O.); Westchester County Medical Center, Valhalla, NY (A.L.P.); St Paul's Hospital, Vancouver, British Columbia, Canada (R.G.C.); University of Florida, Gainesville (T.J.W., C.J.P.); Klinikum Innenstadt der Universita\u00a8t,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blair J.","family":"O'Neill","sequence":"additional","affiliation":[{"name":"the University of British Columbia, Vancouver, British Columbia, Canada (G.B.J.M.); Parke-Davis Pharmaceutical Research, Ann Arbor, Mich (G.C.H., M.I.K., H.E.H., A.C.G.U.); Hospital Clinico Universitaro, Madrid, Spain (C.M.); Dalhousie University, Halifax, Nova Scotia, Canada (B.J.O.); Westchester County Medical Center, Valhalla, NY (A.L.P.); St Paul's Hospital, Vancouver, British Columbia, Canada (R.G.C.); University of Florida, Gainesville (T.J.W., C.J.P.); Klinikum Innenstadt der Universita\u00a8t,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony L.","family":"Pucillo","sequence":"additional","affiliation":[{"name":"the University of British Columbia, Vancouver, British Columbia, Canada (G.B.J.M.); Parke-Davis Pharmaceutical Research, Ann Arbor, Mich (G.C.H., M.I.K., H.E.H., A.C.G.U.); Hospital Clinico Universitaro, Madrid, Spain (C.M.); Dalhousie University, Halifax, Nova Scotia, Canada (B.J.O.); Westchester County Medical Center, Valhalla, NY (A.L.P.); St Paul's Hospital, Vancouver, British Columbia, Canada (R.G.C.); University of Florida, Gainesville (T.J.W., C.J.P.); Klinikum Innenstadt der Universita\u00a8t,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald G.","family":"Carere","sequence":"additional","affiliation":[{"name":"the University of British Columbia, Vancouver, British Columbia, Canada (G.B.J.M.); Parke-Davis Pharmaceutical Research, Ann Arbor, Mich (G.C.H., M.I.K., H.E.H., A.C.G.U.); Hospital Clinico Universitaro, Madrid, Spain (C.M.); Dalhousie University, Halifax, Nova Scotia, Canada (B.J.O.); Westchester County Medical Center, Valhalla, NY (A.L.P.); St Paul's Hospital, Vancouver, British Columbia, Canada (R.G.C.); University of Florida, Gainesville (T.J.W., C.J.P.); Klinikum Innenstadt der Universita\u00a8t,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Wargovich","sequence":"additional","affiliation":[{"name":"the University of British Columbia, Vancouver, British Columbia, Canada (G.B.J.M.); Parke-Davis Pharmaceutical Research, Ann Arbor, Mich (G.C.H., M.I.K., H.E.H., A.C.G.U.); Hospital Clinico Universitaro, Madrid, Spain (C.M.); Dalhousie University, Halifax, Nova Scotia, Canada (B.J.O.); Westchester County Medical Center, Valhalla, NY (A.L.P.); St Paul's Hospital, Vancouver, British Columbia, Canada (R.G.C.); University of Florida, Gainesville (T.J.W., C.J.P.); Klinikum Innenstadt der Universita\u00a8t,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Mudra","sequence":"additional","affiliation":[{"name":"the University of British Columbia, Vancouver, British Columbia, Canada (G.B.J.M.); Parke-Davis Pharmaceutical Research, Ann Arbor, Mich (G.C.H., M.I.K., H.E.H., A.C.G.U.); Hospital Clinico Universitaro, Madrid, Spain (C.M.); Dalhousie University, Halifax, Nova Scotia, Canada (B.J.O.); Westchester County Medical Center, Valhalla, NY (A.L.P.); St Paul's Hospital, Vancouver, British Columbia, Canada (R.G.C.); University of Florida, Gainesville (T.J.W., C.J.P.); Klinikum Innenstadt der Universita\u00a8t,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"Lu\u00a8scher","sequence":"additional","affiliation":[{"name":"the University of British Columbia, Vancouver, British Columbia, Canada (G.B.J.M.); Parke-Davis Pharmaceutical Research, Ann Arbor, Mich (G.C.H., M.I.K., H.E.H., A.C.G.U.); Hospital Clinico Universitaro, Madrid, Spain (C.M.); Dalhousie University, Halifax, Nova Scotia, Canada (B.J.O.); Westchester County Medical Center, Valhalla, NY (A.L.P.); St Paul's Hospital, Vancouver, British Columbia, Canada (R.G.C.); University of Florida, Gainesville (T.J.W., C.J.P.); Klinikum Innenstadt der Universita\u00a8t,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael I.","family":"Klibaner","sequence":"additional","affiliation":[{"name":"the University of British Columbia, Vancouver, British Columbia, Canada (G.B.J.M.); Parke-Davis Pharmaceutical Research, Ann Arbor, Mich (G.C.H., M.I.K., H.E.H., A.C.G.U.); Hospital Clinico Universitaro, Madrid, Spain (C.M.); Dalhousie University, Halifax, Nova Scotia, Canada (B.J.O.); Westchester County Medical Center, Valhalla, NY (A.L.P.); St Paul's Hospital, Vancouver, British Columbia, Canada (R.G.C.); University of Florida, Gainesville (T.J.W., C.J.P.); Klinikum Innenstadt der Universita\u00a8t,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry E.","family":"Haber","sequence":"additional","affiliation":[{"name":"the University of British Columbia, Vancouver, British Columbia, Canada (G.B.J.M.); Parke-Davis Pharmaceutical Research, Ann Arbor, Mich (G.C.H., M.I.K., H.E.H., A.C.G.U.); Hospital Clinico Universitaro, Madrid, Spain (C.M.); Dalhousie University, Halifax, Nova Scotia, Canada (B.J.O.); Westchester County Medical Center, Valhalla, NY (A.L.P.); St Paul's Hospital, Vancouver, British Columbia, Canada (R.G.C.); University of Florida, Gainesville (T.J.W., C.J.P.); Klinikum Innenstadt der Universita\u00a8t,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.G.","family":"Uprichard","sequence":"additional","affiliation":[{"name":"the University of British Columbia, Vancouver, British Columbia, Canada (G.B.J.M.); Parke-Davis Pharmaceutical Research, Ann Arbor, Mich (G.C.H., M.I.K., H.E.H., A.C.G.U.); Hospital Clinico Universitaro, Madrid, Spain (C.M.); Dalhousie University, Halifax, Nova Scotia, Canada (B.J.O.); Westchester County Medical Center, Valhalla, NY (A.L.P.); St Paul's Hospital, Vancouver, British Columbia, Canada (R.G.C.); University of Florida, Gainesville (T.J.W., C.J.P.); Klinikum Innenstadt der Universita\u00a8t,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl J.","family":"Pepine","sequence":"additional","affiliation":[{"name":"the University of British Columbia, Vancouver, British Columbia, Canada (G.B.J.M.); Parke-Davis Pharmaceutical Research, Ann Arbor, Mich (G.C.H., M.I.K., H.E.H., A.C.G.U.); Hospital Clinico Universitaro, Madrid, Spain (C.M.); Dalhousie University, Halifax, Nova Scotia, Canada (B.J.O.); Westchester County Medical Center, Valhalla, NY (A.L.P.); St Paul's Hospital, Vancouver, British Columbia, Canada (R.G.C.); University of Florida, Gainesville (T.J.W., C.J.P.); Klinikum Innenstadt der Universita\u00a8t,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertram","family":"Pitt","sequence":"additional","affiliation":[{"name":"the University of British Columbia, Vancouver, British Columbia, Canada (G.B.J.M.); Parke-Davis Pharmaceutical Research, Ann Arbor, Mich (G.C.H., M.I.K., H.E.H., A.C.G.U.); Hospital Clinico Universitaro, Madrid, Spain (C.M.); Dalhousie University, Halifax, Nova Scotia, Canada (B.J.O.); Westchester County Medical Center, Valhalla, NY (A.L.P.); St Paul's Hospital, Vancouver, British Columbia, Canada (R.G.C.); University of Florida, Gainesville (T.J.W., C.J.P.); Klinikum Innenstadt der Universita\u00a8t,..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112768"},{"key":"e_1_3_2_2_2","unstructured":"Dzau VJ. Molecular and physiological aspects of tissue renin-angiotensin system: emphasis on cardiovascular control. J Hypertens. 1988;6(suppl 3):7S-12S."},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","unstructured":"Rubanyi GM. The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol. 1993;22(suppl 4):1S-14S.","DOI":"10.1097\/00005344-199322004-00002"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","unstructured":"Lu\u00a8scher TF Noll G. Endothelium dysfunction in the coronary circulation. J Cardiovasc Pharmacol. 1994;24(suppl 3):16S-26S.","DOI":"10.1097\/00005344-199400243-00003"},{"key":"e_1_3_2_5_2","unstructured":"Vanhoutte PM. Endothelium and responsiveness of vascular smooth muscle. J Hypertens. 1987;5(suppl 5):115S-120S."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199007053230106"},{"key":"e_1_3_2_7_2","unstructured":"Zeiher AM Schachinger V. Coronary endothelial vasodilator dysfunction: clinical relevance and therapeutic implications. Z Kardiol. 1994;83(suppl 3):7S-14S."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.65.3.116"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116491"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","unstructured":"Harrison DG. Endothelial dysfunction in atherosclerosis. Basic Res Cardiol. 1994;89(suppl 1):87-102.","DOI":"10.1007\/978-3-642-85660-0_8"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","unstructured":"Harrison DG Ohara Y. Physiologic consequences of increased vascular oxidant stresses in hypercholesterolemia and atherosclerosis: implications for impaired vasomotion. Am J Cardiol. 1995:75:75B-81B.","DOI":"10.1016\/0002-9149(95)80018-N"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.79.2.2914347"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.80.3.458"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116183"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","unstructured":"Becker RHA Wiemer G Linz W. Preservation of endothelial function by ramipril in rabbits on a long-term atherogenic diet. J Cardiovasc Pharmacol. 1991;18(suppl 2):S110-S115.","DOI":"10.1097\/00005344-199106182-00023"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.15.3.327"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2526370"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1989.tb03510.x"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(88)90892-2"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.68.2.1991349"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.10.10.5536"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.74.6.8187280"},{"key":"e_1_3_2_23_2","first-page":"529","volume":"48","year":"1983","unstructured":"Foris G, Dezso B, Medgyesi GA, Fust G. Effect of angiotensin II on macrophage functions. Immunology. 1983;48:529-535.","journal-title":"Immunology"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.15.6.666"},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","unstructured":"Sharpe N. The effects of ACE inhibition on progression of atherosclerosis. J Cardiovasc Pharmacol. 1993;22(suppl 9):9S-12S.","DOI":"10.1097\/00005344-199312002-00003"},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","unstructured":"Lu\u00a8scher TF. Endothelium control of vascular tone and growth: potential role in coronary artery disease. In: Reiber JHC Serruys PW eds. Progress in Quantitative Coronary Arteriography. Doerdrecht Netherlands: Kluwer Academic Press; 1994:3-18.","DOI":"10.1007\/978-94-011-1172-0_1"},{"key":"e_1_3_2_27_2","unstructured":"Dawkins R Purcell TS. Investigator's brochure: quinapril hydrochloride (CI-906). Ann Arbor MI: Parke-Davis; May 9 1989."},{"key":"e_1_3_2_28_2","unstructured":"Frank G Knapp L Phelps M Quade M Reiger M. Integrated summary of effectiveness of quinapril (section 8.E. of NDA 19-855). Ann Arbor MI: Parke-Davis; Jan 26 1989."},{"key":"e_1_3_2_29_2","unstructured":"Johnston CI Fabris B Yamada H Mendelsohn FAO Cubela R Sivell D Jackson B. Comparative studies of tissue inhibition by angiotensin converting enzyme inhibitors. J Hypertens. 1989;7(suppl 5):11S-16S."},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1990.tb15862.x"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.75.2.452"},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","unstructured":"Gibson CM Sandor T Stone PH Pasternak RC Rosner B Sacks FM. Quantitative angiographic and statistical methods to assess serial changes in coronary luminal diameter and implications for atherosclerosis regression trials. Am J Cardiol. 1992:69:1286-1290.","DOI":"10.1016\/0002-9149(92)91222-P"},{"key":"e_1_3_2_33_2","unstructured":"SAS Institute Inc. SAS Technical Report P-229: SAS\/STAT Software\u2014Changes and Enhancements. Cary NC: SAS Institute; 1992:287-368. Release 6.07."},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(92)90004-J"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199502233320801"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199502233320802"},{"key":"e_1_3_2_37_2","unstructured":"Haefeli WE Linder L Lu\u00a8scher TF. Blockade of nitric oxide formation inhibits direct vasodilator effects of the ACE inhibitor quinaprilat. Circulation. 1994;90(pt 2):I-137. Abstract."},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)92889-N"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199209033271001"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.19.2.131"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.19.2.117"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/4.1.15S"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2828(90)90115-I"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.18.4.558"},{"key":"e_1_3_2_45_2","first-page":"87","volume":"9","year":"1989","unstructured":"Luskutoff DJ, Sawdey M, Mimuro J. Type 1 plasminogen activator inhibitor. Prog Hemost Thromb. 1989;9:87-115.","journal-title":"Prog Hemost Thromb"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1097\/00041433-199108000-00007"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.90.4.7923694"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00878518"}],"container-title":["Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.CIR.94.3.258","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T16:03:54Z","timestamp":1715529834000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.CIR.94.3.258"}},"subtitle":["The TREND (Trial on Reversing ENdothelial Dysfunction) Study"],"short-title":[],"issued":{"date-parts":[[1996,8]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1996,8]]}},"alternative-id":["10.1161\/01.CIR.94.3.258"],"URL":"https:\/\/doi.org\/10.1161\/01.cir.94.3.258","relation":{},"ISSN":["0009-7322","1524-4539"],"issn-type":[{"value":"0009-7322","type":"print"},{"value":"1524-4539","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,8]]},"assertion":[{"value":"1996-01-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1996-03-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1996-08-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}